Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

60.0%

3 terminated/withdrawn out of 5 trials

Success Rate

40.0%

-46.5% vs industry average

Late-Stage Pipeline

80%

4 trials in Phase 3/4

Results Transparency

200%

4 of 2 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 3
4(100.0%)
4Total
Phase 3(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01811550Completed

Study of Procoagulation Markers in Stroke Patients

Role: collaborator

NCT01369069Phase 3Completed

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial

Role: collaborator

NCT00235495Phase 3Terminated

Albumin in Acute Ischemic Stroke Trial

Role: collaborator

NCT00991029Phase 3Terminated

Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

Role: collaborator

NCT00822900Phase 3Terminated

Progesterone for the Treatment of Traumatic Brain Injury III

Role: collaborator

All 5 trials loaded